Comparative Efficacy of Relapsing Multiple Sclerosis Therapies: Model-Based Meta-Analyses for Confirmed Disability Accumulation and Annualized Relapse Rate

Hennessy, B; Zierhut, ML; Kracker, H; Keenan, A; Sidorenko, T

Hennessy, B (通讯作者),Actel Pharmaceut Ltd, Allschwil, Switzerland.

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022; 64 ():

Abstract

Background: Multiple sclerosis (MS) is an inflammatory autoimmune disorder and the most common cause of non-traumatic disability in young adults. The ......

Full Text Link